http://articles.mercola.com/sites/articles/archive/2006/08/12/are-fda-changes-really-a-superficial-step-in-the-right-direction.aspxThe U.S. FDA has announced plans to make its conflict of interest rules more stringent. This announcement comes in the wake of criticism that many of its advisory board members have undisclosed financial ties to the drug industry. Advisory committeesenCommunityServer 2008.5 SP1 (Build: 31106.3070)